SILO PHARMA, INC. (SILO)
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
Compass Pathways - Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
Trane Technologies to Present at the Oppenheimer Industrial Growth Conference
PermRock Royalty Trust Declares Monthly Cash Distribution
Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
Parsons Demand Response Technology to Optimize and Enable Los Angeles Department of Water & Power’s Operations and Strategic Plan
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering
Innovative Industrial Properties Announces First Quarter 2026 Earnings Release Date and Conference Call
Walker & Dunlop Arranges $105 Million Loan to Refinance Luxury Raleigh Community